Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 5/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.37 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.37 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21865717 | 0.87 | ABCB1 (0.44) | ABCB1BCHECNR2MAOBABCG2 | |
| SCHEMBL21886451 | 0.86 | ABCB1 (0.42) | ABCB1BCHECNR2MAOBABCG2 | |
| SCHEMBL21801131 | 0.86 | CYSLTR1 (0.43) | ABCB1BCHECNR2MAOBCYSLTR1 | |
| SCHEMBL21801118 | 0.84 | CYSLTR1 (0.45) | ABCB1BCHECNR2MAOBCYSLTR1 | |
| SCHEMBL21801063 | 0.84 | CYSLTR1 (0.45) | ABCB1BCHECNR2MAOBCYSLTR1 | |
| SCHEMBL21801062 | 0.84 | CYSLTR1 (0.45) | ABCB1BCHECNR2MAOBCYSLTR1 | |
| SCHEMBL21801232 | 0.83 | MAOB (0.44) | ABCB1BCHECNR2MAOBABCG2 | |
| SCHEMBL21886504 | 0.83 | ABCB1 (0.44) | ABCB1BCHECNR2MAOBABCG2 | |
| SCHEMBL21801191 | 0.83 | CYSLTR1 (0.45) | ABCB1BCHECNR2MAOBCYSLTR1 | |
| SCHEMBL21801083 | 0.83 | CYSLTR1 (0.45) | ABCB1BCHECNR2MAOBCYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3849966-B1 | FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | HOFFMANN LA ROCHE (CH) | 2023-10-25 | — | — | EP | disclosed |
| WO-2020052774-A1 | FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2020-03-19 | — | — | WO | disclosed |
| WO-2020053249-A1 | FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2020-03-19 | — | — | WO | disclosed |